Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer — Oct 17th, 2024

Palvella Therapeutics Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment banking at Goldman Sachs WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -...

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer — Oct 17th, 2024

Palvella Therapeutics Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment banking at Goldman Sachs WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -...

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer — Oct 17th, 2024

Palvella Therapeutics Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment banking at Goldman Sachs WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -...

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer — Oct 17th, 2024

Palvella Therapeutics Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment banking at Goldman Sachs WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -...

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer — Oct 17th, 2024

Palvella Therapeutics Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment banking at Goldman Sachs WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -...

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer — Oct 17th, 2024

Palvella Therapeutics Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment banking at Goldman Sachs WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -...

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer — Oct 17th, 2024

Palvella Therapeutics Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment banking at Goldman Sachs WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -...

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer — Oct 17th, 2024

Palvella Therapeutics Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment banking at Goldman Sachs WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -...

Lifecore Biomedical Announces Cooperation Agreement with 22NW — Jul 1st, 2024

Lifecore Biomedical, Inc. Provides for the Addition of 22NW Nominees Jason Aryeh and Matthew Korenberg, as Well as Humberto Antunes and Paul Johnson, to the Board CHASKA, Minn., July 01, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company�...

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer — Oct 17th, 2024

Palvella Therapeutics Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment banking at Goldman Sachs WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -...